Frederic Zecri
35Patents
6h-index
90Co-inventors
68Inventor score
Filing activity: Sep 12, 2003 → May 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10906867B2 | Lipids and lipid compositions for the delivery of active agents | Chemistry; Metallurgy | 37 | Active |
| US8673848B2 | Synthetic apelin mimetics for the treatment of heart failure | Human Necessities | 37 | Active |
| US9949979B2 | Use of inhibitors of the activity or function of PI3K | Emerging Cross-Sectional Technologies | 9 | Active |
| US9763952B2 | Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives | Emerging Cross-Sectional Technologies | 9 | Active |
| US9067971B2 | Synthetic apelin mimetics for the treatment of heart failure | Human Necessities | 8 | Active |
| US9266925B2 | Cyclic polypeptides for the treatment of heart failure | Chemistry; Metallurgy | 6 | Active |
| US10786576B2 | Fatty acids and their use in conjugation to biomolecules | Chemistry; Metallurgy | 5 | Active |
| US10676499B2 | 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA | Chemistry; Metallurgy | 5 | Active |
| US10059655B2 | Lipids and lipid compositions for the delivery of active agents | Chemistry; Metallurgy | 4 | Active |
| US7799812B2 | Reverse isoxazoles | Chemistry; Metallurgy | 4 | Active |
| US8921307B2 | Synthetic linear apelin mimetics for the treatment of heart failure | Human Necessities | 4 | Active |
| US10005829B2 | Synthetic linear apelin mimetics for the treatment of heart failure | Chemistry; Metallurgy | 3 | Active |
| US9908919B2 | Cyclic apelin derivatives for the treatment of heart failure | Human Necessities | 3 | Active |
| US9982017B2 | Synthetic apelin mimetics for the treatment of heart failure | Human Necessities | 3 | Active |
| US9683019B2 | Cyclic polypeptides for the treatment of heart failure | Chemistry; Metallurgy | 3 | Active |
| US9931372B2 | Synthetic apelin fatty acid conjugates with improved half-life | Chemistry; Metallurgy | 3 | Active |
| US9683018B2 | Disulfide cyclic polypeptides for the treatment of heart failure | Chemistry; Metallurgy | 3 | Active |
| US11466048B2 | 3′ end caps, 5′ end caps and combinations thereof for therapeutic RNA | Chemistry; Metallurgy | 3 | Active |
| US9340582B2 | Bioconjugates of synthetic apelin polypeptides | Chemistry; Metallurgy | 2 | Active |
| US11878973B2 | Bicyclic compounds and their uses | Chemistry; Metallurgy | 2 | Active |
| US10426737B2 | Lipids and lipid compositions for the delivery of active agents | Chemistry; Metallurgy | 1 | Active |
| US11013696B2 | Lipids and lipid compositions for the delivery of active agents | Chemistry; Metallurgy | 1 | Active |
| US8653092B2 | Tetrahydro-pyrido-pyrimidine derivatives | Human Necessities | 1 | Active |
| US11752211B2 | Fatty acids and their use in conjugation to biomolecules | Chemistry; Metallurgy | 0 | Active |
| US8993619B2 | Cyclic bridgehead ether DGAT1 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.